Innovative Research Award
Danyelle Townsend
Medical University of South Carolina, United States
| Danyelle Townsend |
| Affiliation |
Medical University of South Carolina |
| Country |
United States |
| Scopus ID |
7202240755 |
| Documents |
173 |
| Citations |
14,308 |
| h-index |
53 |
| Subject Area |
Molecular Pharmacology |
| Event |
International Molecular Biologist Awards |
| Google Scholar ID |
zaTtq2UAAAAJ |
Danyelle Townsend is a molecular pharmacology researcher recognized for contributions in understanding biochemical mechanisms associated with cellular defense, drug response, and human disease. Her academic work has focused on glutathione metabolism, detoxification pathways, and molecular factors influencing therapeutic outcomes. This article presents a scholarly overview of her research profile and recognition through the Innovative Research Award.
Abstract
The research profile of Danyelle Townsend reflects sustained investigation into molecular pharmacology, particularly the biological roles of glutathione-related pathways. Her studies have contributed to broader understanding of oxidative stress, cancer biology, and cellular protection mechanisms. Key publications have examined glutathione functions and drug resistance processes. [1]
Keywords
Molecular Pharmacology; Glutathione; Cancer Research; Drug Resistance; Oxidative Stress; Biomedical Science.
Introduction
Molecular pharmacology investigates interactions between biological systems and therapeutic compounds. Research in this field provides insight into disease mechanisms and supports development of improved treatment strategies. Townsend’s work has emphasized molecular pathways that regulate cellular responses to environmental and therapeutic challenges. [2]
Research Profile
Danyelle Townsend is affiliated with the Medical University of South Carolina and has developed expertise in molecular mechanisms associated with pharmacological responses. Her scholarly record includes 173 documents, 14,308 citations, and an h-index of 53, demonstrating notable engagement within biomedical research literature.
Research Contributions
Major contributions include investigations into glutathione metabolism, glutathione-S-transferase activity, and molecular pathways affecting cancer therapy. These studies have provided evidence regarding antioxidant defense and mechanisms involved in therapeutic resistance. [3]
Publications
- The importance of glutathione in human disease, 2003.
- The role of glutathione-S-transferase in anti-cancer drug resistance, 2003.
- Glutathione S-transferase polymorphisms: cancer incidence and therapy, 2006.
Research Impact
The impact of this research is reflected through citation activity and continued relevance of molecular detoxification pathways in biomedical science. The findings support ongoing investigations into personalized medicine and therapeutic optimization.
Award Suitability
The Innovative Research Award recognizes researchers whose work demonstrates scientific contribution, methodological advancement, and meaningful influence within their discipline. Townsend’s publication record and research focus align with these academic criteria.
Conclusion
Danyelle Townsend’s research represents sustained contributions to molecular pharmacology through studies of cellular defense mechanisms, drug resistance, and disease-related biochemical processes.
External Links
References
- Elsevier. (n.d.). Scopus author details: Danyelle Townsend, Author ID 7202240755. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=7202240755
- Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene. 2003;22:7369–7375.
- Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomedicine & Pharmacotherapy. 2003;57:145–155.
DOI: https://doi.org/10.1016/S0753-3322(03)00022-0
- Tapiero H, Townsend DM, Tew KD. The antioxidant role of selenium and seleno-compounds. Biomedicine & Pharmacotherapy. 2003;57:134–144.
- McIlwain CC, Townsend DM, Tew KD. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene. 2006;25:1639–1648.